Indeed, transient activation of TLR9 was shown to decrease parenchymal and vascular Aβ pathology and improve cognitive function in various AD mouse models and in squirrel monkeys [130,192,193], suggesting that the initial activation of inflammation may be beneficial. Here, TLR9 is linked to Alzheimer disease.